Four major antigenic sites have been delineated on the spike protein (S) of the porcine enteric coronavirus transmissible gastroenteritis virus (TGEV) in previous topological studies using monoclonal antibodies (MAbs). Correlation of these sites with the physical structure of the protein was achieved by use of different approaches. Recombinant pEX plasmids directing the synthesis of various fused S polypeptides were constructed. A hybrid protein containing nine S-specific residues (363 to 371) was shown to express site C epitopes. The other sites were localized through study of the antigenic activity of fragments generated by controlled cleavage of the native protein with different endopeptidases. Two identified cleavage products of 26K and 13K, immunoreactive to site A-B-and site D-specific MAbs respectively, could be aligned on the S primary structure according to N-terminal sequence data. This led us to propose that the major neutralization domain A-B is contained in a region of approximately 200 residues with residue 506 as its N boundary. Similarly, site D epitopes should be located within a stretch of 130residues, starting at 82 residues from the N terminus. Point mutations identified by direct RNA sequencing of neutralization-resistant mutants were consistent with the proposed location of these sites.
Introduction
Transmissible gastroenteritis virus (TGEV) causes an acute and usually fatal enteric disease in newborn piglets. Together with the murine hepatitis virus (MHV) and infectious bronchitis virus (IBV), TGEV is one of the most well studied coronaviruses, a family of enveloped positive-stranded RNA viruses (for review, see Spaan et al., 1988) . The organization of the TGEV genome has been established (Rasschaert et al., 1987) as well as the sequence of the genes encoding the structural and most of the non-structural proteins (Kapke & Brian, 1986; Rasschaert & Laude, 1987; Rasschaert et al., 1987; Jacobs et al., 1987) . TGEV virions contain three proteins, a nucleocapsid protein and two envelope glycoproteins, M (29K) and S (220K) (Garwes & Pocock, 1975; Laude et al., 1986) . The spike protein S is 1431 residues long, highly glycosylated, with a membraneanchoring domain near its carboxy-terminus and a globular domain assumed to correspond to its aminoterminal half (Rasschaert &Laude, 1987) . Competition studies using monoclonal antibodies (MAbs) has led to the prediction of at least four main antigenic sites (Delmas et al., 1986; Garwes et al., 1987; Correa et al., 1988) .
Major antigenic sites, designated A, B, C and D, have been delineated using the library of MAbs established in our laboratory. Most of the epitopes critical for neutralization were found to be clustered in the immunodominant A and B sites, but the other two sites contained subsidiary neutralization epitopes. The A, B and D sites have been found to be highly conserved among TGEV strains, whereas antigenic variation was observed on site C epitopes Delmas et al., 1986) . In order to gain information on the antigenic structure of S at the molecular level, but also to investigate possible vital functions of distinct epitopes, we have undertaken a systematic mapping of the antibody-binding regions. The present study reports the localization of four antigenic sites on the primary structure of S by combined approaches including production of antigenically active fragments of the protein by bacterial expression or proteolytic treatment, and analysis of epitope mutants.
supplemented with 5~ newborn calf serum (NCS). The selection of epitope mutants resistant to neutralization has already been reported (Delmas et al., 1986) . The 23 anti-TGEV S MAbs used in this study are listed in Table 1 . Their characteristics in terms of polypeptide specificity (S and/or S') and neutralizing activity have been reported . Two neutralizing MAbs directed against site C (CVIoTGEV-57.24 and -57.57) were provided by A. van Nieuwstadt (Central Veterinary Institute, Lelystad, The Netherlands).
Construction ofpEX clones.
The cDNA clones of the TGEV S protein in pBR322 have been described (Rasschaert &Laude, 1987) . cDNA fragments excised by restriction enzymes as specified in Fig. 1 were resolved in 1 ~ low melting point agarose, then purified using the Geneclean kit (New England Biolabs). The fragments were ligated into compatible sites of the pEX1, pEX2 or pEX3 expression vectors (Stanley & Luzio, 1984) as indicated. The 5' protruding ends of inserts and vectors were filled using Klenow DNA polymerase. Escherichia coli strain MC1061 carrying plasmid pCI (Kin a, Clts 857) was used as the pEX host. Recombinant plasmids were introduced into cells via the Hanahan procedure. Screening of the library was done by hybridization to inserts excised from relevant cDNA clones, followed by restriction analysis. DNA manipulations were performed following standard protocols (Maniatis et al., 1982) .
Construction ofpEX sublibraries. The random sublibrary designated pEXS was generated by sonication (disintegrator MK2-150W; MSE) of the insert from one epitope-expressing clone; resulting fragments (150 + 50 nucleotide long) were repaired with the Klenow fragment and then ligated into the Sinai-cut, calf intestine phosphatase-treated pEX2 plasmid. The pEXB sublibrary was obtained by resection of a linearized plasmid using Bal 31 exonuclease ('slow form', IBI, 0-25 units per rtg of DNA, 30 °C for 50 min in the manufacturer's buffer), followed by self ligation.
lmmunoscreening of bacterial colonies. Colonies transferred to a nitrocellulose membrane (BA85, Schleicher & Schuell) were incubated at 25 °C overnight for plasmid amplification; then expression of the pEX fusion gene was induced by shifting to 42 °C for 2 h (Stanley & Luzio, 1984) . Cell lysis was performed by holding the membranes in a CHC13-saturated atmosphere. Positive colonies were visualized according to Huynh et al. (1985) , using 1:100 diluted ascites fluids and lzSI-labelled Protein A (Amersham, 2 x 106 c.p.m, per disk).
Isolation of expression products and Western blot. Expression was
induced as above in an exponential culture (optical density at 600 nm of 0.5). The cro-fl-galactosidase fusion proteins were extracted as Triton X-100-insoluble pellets (Stanley & Luzio, 1984) . SDS-solubilized proteins corresponding to 0.5 ml of culture were resolved by 10~ PAGE, then electroblotted using a Milliblot SDE system (Millipore). MAb binding was visualized as in the colony blot test.
Generation of S-S" proteolytic fragments.
Radiolabelled cytosol samples were prepared as described with some modifications. Confluent PD5 cell monolayers in Petri dishes (10 cm diam., Costar) were infected (or mock-infected) at a multiplicity of 50 p.f.u, per cell and maintained at 38 °C in 10 ml cystine-depleted DMEM with 2~ NCS. At 3 h post-infection (p.i.) 7 ml of medium was discarded and [35S]cysteine (> 600 Ci/mmol, Amersham) was added at 100 ~tCi/ml. At 8 to 9 h p.i., the medium was discarded, the cell sheets were rinsed, and then scraped into 4-5 ml chilled radioimmunoprecipitation assay (RIPA) lysis buffer (10 mM-Tris-HC1 pH 8, 2% Triton X-100, 0.15 M-NaC1, 0-6 M-KCI, 0-5 mM-MgCI2, 103 kallikrein inhibitor units/ml aprotinin). After 1 h, this material was ultracentrifuged for 1 h at 35000 r.p.m, in a 50Ti rotor (Beckman). The supernatants were stored at -70 °C. Proteolytic digestions were performed by incubating 50 ~tl of cytosol at 37 °C for 2 h with the following volumes of enzyme solution (10 mg/ml): 3 ~tl of TLCK c~-chymotrypsin (Sigma), 3 I11 of collagenase from Ctostridium histolyticum (Boehringer Mannheim), 1 ~tl of TPCK trypsin (Sigma) or 3 ~tl of V8 protease (Miles Laboratories). The reactions were terminated by adding 40 mg/ml bovine serum albumin (fraction 5, Boehringer Mannheim). TPCK and TLCK (2 mg/ml, Sigma) were also added to stop chymotrypsin and trypsin digestion, respectively.
Immunoprecipitation assays. Aliquots of 50 ~tl of digested products were incubated for 2 h at 37 °C with 5 ~1 of undiluted hybridoma ascites fluid. Antigen-antibody complexes were bound to 80 Ixl of a 1 : 1 slurry of Protein A-Sepharose 4B (Pharmacia) under gentle agitation for 1 h at room temperature. The beads were washed six times with l ml of RIPA buffer and once with Tris buffer, then treated for 2 min at 100 °C in Laemmli's denaturing buffer plus 5~ 2-mercaptoethanol, and centrifuged. Resulting supernatants were subjected to electrophoresis on a 9 to 20~ polyacrylamide gradient gel which was then processed for fluorography. ~4C-methylated protein Mr standards (Amersham) were used.
Amino-terminal sequencing of proteolytic fragments. Tritium-labelled proteolytic fragments were prepared as described above with the following modifications. Infected monolayers were labelled using 1 mCi/ml [3H]valine (CEA France; 40 Ci/mmol), or 0.5 mCi/ml [3H]threonine (Amersham; 20 Ci/mmol) or 0-5 mCi/ml [3H]isoleucine (Amersham; 100 Ci/mmol). Additional inhibitors were used following chymotrypsin treatment: soybean trypsin inhibitor (Sigma; 3 mg/ml), PMSF (Sigma; 0.2 raM) and aprotinin (2 x 103 kallikrein inhibitor units/ml). Immunoprecipitation was done by adding 100 ~tl of ascites fluid to 15 ml of digested cytosol (obtained by pooling the RIPA cell extracts from three Petri dishes), followed by 400 p.l of Protein ASepharose beads. After a 2 h agitation, the beads were washed with 100 ml of RIPA buffer in eight steps, heated for 2 rain in 200 ~tl Laemmli's buffer and centrifuged. PAGE of resulting supernatants was performed. A piece of gel containing the fragment was excised after localization of its position by reference to that of Mr standard proteins stained with CoomaSsie blue (Pharmacia; 14K to 94K), and then electroeluted as described previously . The location of tritiated residues on recovered material was determined by automated gas-phase analysis on an Applied Biosystems 470A apparatus. Lactoglobulin (200 pmol) was included as a non-labelled control in order to check the sequential Edman degradation. Radioactivity from eluted fractions was counted by liquid scintillation (Minaxi 4000, Packard).
Dideoxynucleotide sequencing of supercoiled plasmid DNA and of genomic RNA. Sequencing of double-stranded DNA templates was done according to Lim & P+ne (1988) . Plasmid DNA prepared by the alkali-SDS method was precipitated by 6.5~ polyethylene glycol 8000 plus 0.8 M-NaC1 (Lin et al., 1985) , and then denatured by NaOH. Two oligonucleotides (151 and 190) complementary to pEX DNA sequences were used as primers. Reverse transcription of genomic RNA was performed as originally described by Zimmern & Kaesberg (1978) . RNA matrixes were obtained by proteinase K-SDS treatment of virions semi-purified by ultracentrifugation through a 25~ glycerol cushion, followed by phenol-chloroform extraction. After precipitation with 2 M-LiCI, RNA was resuspended in water and heat-denatured (100 °C for 1 min). Priming was done using 20-met oligonucleotides complementary to the TGEV S sequence (Rasschaert et al., 1987) . The elongation reaction was performed at 42 °C for 20 min using l to 2 ~tg RNA per sequence, avian myeloblastosis virus reverse transcriptase (Applig+ne), [35S]dATP (Amersham) and a deoxynucleotide :dideoxynucleotide ratio of 3.75:1, 5:1, 6:1 and 12.5:1 respectively, for nucleotides T, C, G and A. The samples were analysed on a 6% acrylamide-8 M-urea gel. The synthetic oligonucleotides were synthesized on a Biosearch 8600 apparatus.
Results

Subcloning of S cDNA fragments into pEX vector and identification of clones expressing epitopes
The inducible pEX bacterial expression system was used to produce fragments of TGEV S as a C-terminal extension of cro-fl-galactosidase. A library was created by insertion of seven partially overlapping cDNA fragments into compatible pEX plasmids. The fragments were between 500 and 1500 nucleotides in size and covered the entire S gene, except for 105 nucleotides at the 5' end ( Fig. 1 ). Six to 10 recombinant clones from each construction were examined for expression of a chimeric protein after heat induction. Then two or three of the clones that produced the highest level of fusion protein were subjected to colony blot immunoscreening with our panel of anti-S MAbs. None of the MAbs directed against A, B and D sites or unrelated epitopes was found to react with any of the expression products. In contrast, MAbs 3b. 5, 10.4 and 11.20, all defining site C, recognized the expression products relative to fragments 1, 3 and 4 (data not shown).
Generation of pEX sublibraries for delineating site C
Random fragments averaging 150 nucleotides produced by sonication of the insert excised from pEXG16 (fragment 3 in pEX3) by SmaI-HindIII digestion were subcloned into a SmaI-cut dephosphorylated pEX2 plasmid. The resulting sublibrary was screened against MAb 3b. 5. Direct supercoiled plasmid sequencing of 10 of the positive clones was performed using oligonucleotide 151 as a 3' primer. The shortest insert, which was carried by plasmid pEXS8, was 89 nucleotides long and encoded 28 S-specific amino acids (Fig. 2) .
PAGE analysis of the pEXS8 expression product revealed an M, value of 33K to 35K (Fig. 3b , lane 2), whereas the predicted M, of the cro-fl-galactosidase chain is 117K to 119K (Stanley & Luzio, 1984) . Upon reexamination of the nucleotide sequence, it appeared that the S-specific sequence was bound 2495 bp upstream of the 3' end of the lacZ' gene. The occurrence of a large deletion, most likely during the vector dephosphorylation step, thus explains the unexpected M, of the pEXS8 expression product. This was confirmed by sequencing the opposite strand with primer 190 which is specific for the truncated pEX (Fig. 2) .
Sequencing of the other nine random inserts, which ranged in size from 129 to 259 bp, revealed a striking feature: the S cDNA sequences were all 5' coterminal together with that of the pEXS8 insert (data not shown). This suggested that the deduced N-terminal residues common to these 10 fusion proteins corresponded to one limit of site C. In order to determine the C-terminal limit of the antibody-binding site, we produced a second sublibrary by nuclease Bal 31 resection of HindIII-cut pEXS8 plasmid (HindIII was a unique restriction site located downstream of the S sequence; see Fig. 2 ). A series of plasmids from clones positive in colony blot immunoscreening were sequenced as above using primer 190. Thus the S cDNA sequences identified as the three shortest, encoded nine or l0 amino acids (Fig. 3a) . The immunoreactivity towards MAb 3b.5 of the related expression products was confirmed by Western blotting (Fig. 3 b) . The immunoreactivity of these three fusion proteins towards the panel of site C-specific MAbs was also compared in a colony blot test (Fig. 3 c) . MAbs 57.24 and 57.57 exhibited a reactivity similar to that of 3b. 5, whereas the reactivity of MAbs 10.4 and 11.20 was weaker as found also with the fusion protein of 28 residues. 
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Immunoprecipitation profiles of S proteolytic fragments
Partial cleavages of the protein were performed with four different endopeptidases. The resulting fragments were subjected to immunoprecipitation using anti-S-S' or anti-S' MAbs. S' (175K, formerly called E'2), designates the underglycosylated precursor of S (220K); the two species are present in similar amounts in infected cell extracts . Four main profiles were characterized following collagenase cleavage (Fig. 4) . . Site C-specific MAbs and MAb 67.9 precipitated most of these fragments weakly (profile 3). The presence of 22K and 65K bands (profile 4) was typical for four out of six of the tested S'-specific MAbs. Moreover, these MAbs precipitated high Mr material (> 250K) which was never observed with uncleaved S material and was likely to represent aggregated fragments. An overall view of the profiles generated by collagenase and by the other assayed proteases (see below) is presented in Table 1 . The chymotrypsin digestion profiles obtained with the S-specific MAbs showed essentially quantitative dissimilarities (Fig. 5) . As a main feature, a small fragment of 13K (CT-13K) strongly reacted with all site D-specific MAbs. In particular, MAbs 78.17 and 69.21 precipitated CT-13K as a major fragment. Most of the fragments from CT digestion were precipitated weakly or not at all, by site A-, B-and C-specific MAbs. Again, the S'-specific MAbs yielded a unique profile composed of 21/28K, 50K and 72/86K species and of aggregated material (data not shown). Controlled trypsin digestion produced three 'nested' profiles: 90/175K bands were precipitated by site A-, B-, C-and D-specific MAbs, an :~ Number refers to precipitation pattern shown for respective enzymes (partial data in Fig. 1 and 2 
N-terminal sequencing of low Mr reactive fragments
The above experiments enabled us to characterize two S cleavage products, CO-26K and CT-13K, which potentially retained a substantial reactivity towards MAbs defining sites A-B or D, respectively. The effect of nonreducing conditions on the mobility of these fragments was examined in order to determine whether or not they could be linked through a disulphide bridge to a larger immunoprecipitated fragment. No change was detected, thus establishing that the antibody-binding site was on the fragment itself in both cases (data not shown).
Hence, it was of interest to orientate CO-26K and CT-13K on the primary structure of S. Radiosequencing proved to be necessary for determination of their N-terminal extremity owing to the limiting amount of cleavage product. Analysis of the [3H]threonine-or [3H]isoleucine-labelled CO-26K fragment precipitated by MAb 48.1 (site A-B) identified Thr residues at positions 4, 6 and 11, and Ile residues at positions 7, 10, 12 and 25 ( Fig. 6a and b) . Sequencing of the CT-13K fragment precipitated by MAb 40.1 (site D) revealed Val residues at positions 8, 9, 10, 14 and 19 (Fig. 6c) . However, the yield of residue 14 was lower than that of residue 19, indicating the presence of more than one fragment. Indeed, reverse-phase HPLC revealed that the material consisted of two species in the ratio of 3:1. Sequencing of the major species no longer identified a Val residue at position 14 (data not shown). As mentioned above, a CT-13K fragment also reacted weakly with many non-site D-specific MAbs. Analysis of the labelled CT-13K fragment prepared with MAb 20.9 (site A) also revealed Val residues at positions 8, 9, 10 and 19 (Fig. 6d) .
Sequence analysis of epitope mutants
Identification of amino acid changes conferring neutralization resistance to previously selected independent epitope mutants was a way to identify precisely the structure of the different antigenic sites. The sequence of the gene portions encoding all of the CO-26K and CT-13K regions and of about 200 nucleotides covering the region predicted to encode site C were determined by reverse transcription of the genomic RNA using appropriate DNA primers. The predicted amino acid sequence for the parental virus agreed completely with that determined for cDNA clones (Rasschaert & Laude, 1987) , except for Leu instead of Ile at position 690 (26K region). As shown in Table 2 , each mutant analysed contained a single nucleotide substitution specifying one non-conservative amino acid change.
Discussion
Although there are several published reports dealing with the physical mapping of B cell-related epitopes on coronavirus MHV and IBV spike proteins (Makino et al., 1987; Cavanagh et al., 1988; Talbot et al., 1988; Lenstra et aL, 1989; Luytjes et al., 1989) , the emerging picture is still largely incomplete. The present study provides molecular data on the antigenic structure of the TGEV S protein. Our findings establish that four previously delineated major antigenic sites (Delmas et al., 1986) are all located in the amino-terminal half of the polypeptide chain.
In the first series of experiments, large restriction fragments or small random fragments of the S protein were expressed in E. coli using the pEX system. Only epitopes belonging to site C could be detected by this approach. Subsequently, accurate mapping of this site could be achieved through subcloning in pEX of Bal 31-resected cDNA fragments. A hybrid protein containing nine amino acid residues was shown to be recognized by all the available five site C-specific MAbs (Fig. 3) . From this result it was concluded that the sequence stretching from residue 363 to 371 of the mature protein is an essential component of site C. There is thus a good correlation between these data and those obtained through a peptide scanning approach (W. Posthumus et al., IV International Coronavirus Symposium, Cambridge, July 1989) . The existence of a potential antigenic site at this position was predicted by only one of the five assayed antigenicity algorithms, i.e. the accessibility analysis (Janin, 1979) , which gave a high score for the first five residues. Besides, no ordered secondary structure was predicted in the 4~3 surrounding residues (Gibrat et al., 1987) , which suggests that site C is located on an extended loop structure protruding at the spike surface.
Use of the pEX system in the case of MHV and IBV proteins (Luytjes et al., 1989; Lenstra et al., 1989) enabled the identification of potentially linear epitopes in the amino-terminal region of the $2 subunit, but not in the S1 (amino) subunit, in contrast to our findings on TGEV. The successful expression of site C as a bacterial fusion protein is consistent with other observations which suggest that it is composed of largely conformation-independent epitopes: glycosidase treatment affected binding of site C-specific MAbs to S protein moderately, in contrast to site A-, B-and D-specific MAbs (B. Delmas, unpublished results), and a high proportion of site C-specific hybridomas were isolated using a Western blotted, partially denatured antigen for screening (A. Van Nieuwstadt, personal communication) .
Additional information about the structure of site C was provided by comparison of the homologous sequences available for selected mutants of Purdue virus, for one TGEV variant strain and for one strain of feline infectious peritonitis virus (FIPV). It appears from the data in Table 3 that each of the three residues Phe(366)-Ser-Tyr(368) is critical for neutralization of infectivity. Despite adjacent amino acid changes, mutants 3b. 5 and 10.4 did not exhibit functional reciprocity (i.e. 3b.5 mutants were still recognized by MAb 10.4). Also neutralization resistance was not always associated with loss of antibody-binding (e.g. 10.4 mutants). Finally, residues 365 to 368 might not be crucial for binding by non-neutralizing MAb 11.20 (which does not discriminate the FIPV strain). Altogether, the above findings lend support to the view that the sequence of nine amino acids corresponding to site C comprises several potentially linear epitopes having distinct functional properties. This is not surprising in the light of recent studies which show that only four to five residues determine specificity and binding energy in epitopes (Geysen et al., 1988) . Bacterial expression of several large fragments covering the entire S polypeptide (except the 19 N-terminal residues) failed to produce fusion proteins expressing sites A, B or D. The approximate location of the latter sites was determined through the following two-step approach, which is theoretically more appropriate for mapping conformation-dependent epitopes: immunoanalysis of proteolytic fragments generated from the native protein and microsequencing of the smallest fragment retaining substantial antigenic activity. The results obtained using four different endopeptidases were in agreement with the previously proposed epitope map, as MAbs defining the same antigenic site yielded a similar profile of cleavage products (Table 1) . However, sites A and B could not be distinguished in the present study, consistent with the fact that potentially they share a common epitope (MAb 48.1). Also, these data indicated that site D was composed of two distinct subsites (see Table 1 ), a finding which seems to be functionally relevant because the two site D-specific MAbs capable of mediating virus neutralization belong to the same subsite. Finally, the fragmentation analysis strengthened our earlier assumption (Delmas et al., 1986) that MAbs against the S' species define a class of epitopes quite distinct and possibly distant from those recognized by S-S' MAbs.
The above experiments allowed the identification of two antigenic cleavage products of limited size which subsequently could be orientated on the S polypeptide chain by partial amino acid sequencing (Fig. 6) . Collagenase digestion produced a 26K fragment expressing all the epitopes belonging to the antigenic domain A-B. Comparison of the radiosequencing data with the amino acid sequence identified unequivocally the Nterminal residue of CO-26K as serine 506 of the mature S protein (Fig. 7) . The cleavage appeared to occur just behind a proline, whereas the cleavage site of collagenase from C. histolytieum usually involves a proline at position _+2; however, the substrate specificity of this enzyme has not yet been fully documented (Van Wart & Steinbrink, 1985) . The C terminus of CO-26K was not determined but, on account of the size of the fragment and the presence of five potential N-linked glycosylation sites, it can be predicted to be located around the proline residue 718. Accordingly, antigenic sites A and B should be located within a stretch of about 200 residues with its carboxy terminus near the middle of the S chain. Further evidence was afforded by the localization of point mutations in the pertinent gene of escape mutants (Table  2 ). The changes conferring neutralization resistance to MAbs 20.9 (site A) and 48.1 (site A-B) were located within the N-terminal third of CO-26K (Fig. 7) . The distance between the two sites of mutation, i.e. 37 residues, is consistent with our earlier observation that MAb 48.1 still recognized escape mutants of MAb 20.9 and vice versa. Escape mutations of site A have also been mapped in this region of S by another group (L. Enjuanes et al., IV International Coronavirus Symposium, Cambridge, July 1989).
Radiosequencing also enabled us to localize unambiguously the chymotrypsin cleavage fragment CT-13K, which strongly reacted to all site D-specific MAbs. Its N terminus was found to correspond to the S residue Asn(82) (Fig. 7) . The immediate upstream residue was tryptophan, an aromatic amino acid which frequently precedes the chymotrypsin cleavage site (Keil, 1987) . The C terminus of CT-13K might be located around the triplet of aromatic residues, Trp-Trp-Phe, found at positions 210 to 212 as the fragment is approximately 130 residues long and devoid of an N-glycosylation site. Thus, site D epitopes should be included in the amino acid stretch 82 to 212. The location of point mutations affecting the integrity of the epitope reacting with MAb 40.1 at positions 147 and 149 fully supports this conclusion. One amino acid change leading to neutralization resistance has also been found in the N-terminal region of the IBV S protein . Finally, our fragmentation analysis suggested that the unrelated epitopes recognized by MAbs 44.4 and 6.179 are also located in the region 82 to 212 of TGEV S.
Taken together, the above results led to the conclusion that the A-B domain, the D site and the C site occupy physically well distinct regions of the S molecule. Nevertheless, as mentioned in the Results section, the CT-13K fragment appeared to exhibit a weak reactivity towards non-site D-specific MAbs, in particular site A-B-specific MAbs. This might be explained by the involvement of residues of the CT-13K region in the antibody-binding site of A and B epitopes. Recent data suggesting that site A-specific MAbs recognize the Nterminal region of S (L. Enjuanes et al., IV International Coronavirus Symposium, Cambridge, July 1989), brings some support to this hypothesis. It should be pointed out, however, that a CT-13K fragment was also weakly revealed by two of the three site C-specific MAbs and by two of the five S'-specific MAbs (data not shown). Therefore the possibility should not be ignored that a non-covalent interaction between the CT-13K region and another region of the S molecule might enable some CT-13K fragments to coprecipitate with large fragments.
In contrast to site C, sites A, B and D are extensively conserved among TGEV strains. Furthermore, all MAbs defining the major neutralization domain A-B have been shown to react with FIPV (strain 79-1146), whereas site D-specific MAbs, as well as two MAbs directed against unrelated epitopes positioned in the same region, exhibited no cross-reactivity (Delmas et al., 1986; Laude et al., 1988) . The physical location of these sites provides a molecular basis for a better understanding of the antigenic relationship between TGEV and FIPV. An optimal alignment of their predicted amino acid sequences in the 26K (A-B) and 13K (D) regions revealed a homology level of 92 and 25%, respectively (sequence data from FIPV S; de Groot et al., 1987) . This led us to propose that the high level of cross-neutralization observed between the porcine, feline and canine coronaviruses (Horzinek et al., 1982) is due to the clustering of most of the critical neutralization epitopes within the structurally conserved and immunodominant 26K region. Elucidating the biological function of the virus-and group-specific regions represents an enticing area for future research.
